BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 24833897)

  • 1. Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease.
    Woods JA; Wheeler JS; Finch CK; Pinner NA
    Int J Chron Obstruct Pulmon Dis; 2014; 9():421-30. PubMed ID: 24833897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of corticosteroid use in outpatient treatment of exacerbated COPD - Study protocol for a randomized, double-blind, non-inferiority study, (The RECUT-trial).
    Urwyler P; Boesing M; Abig K; Cattaneo M; Dieterle T; Zeller A; Bachler H; Markun S; Senn O; Merlo C; Essig S; Ullmer E; Rutishauser J; Schuurmans MM; Leuppi JD
    Trials; 2019 Dec; 20(1):727. PubMed ID: 31842993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exacerbation recovery patterns in newly diagnosed or maintenance treatment-naïve patients with COPD: secondary analyses of TICARI 1 trial data.
    Mannino DM; Clerisme-Beaty EM; Franceschina J; Ting N; Leidy NK
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1515-1525. PubMed ID: 29785101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease.
    Walters JA; Tan DJ; White CJ; Wood-Baker R
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD006897. PubMed ID: 29553157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of different corticosteroid regimes for hospitalised patients with exacerbated COPD: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials.
    Sivapalan P; Rutishauser J; Ulrik CS; Leuppi JD; Pedersen L; Mueller B; Eklöf J; Biering-Sørensen T; Gottlieb V; Armbruster K; Janner J; Moberg M; Lapperre TS; Nielsen TL; Browatzki A; Mathioudakis A; Vestbo J; Schüetz P; Jensen JU
    Respir Res; 2021 May; 22(1):155. PubMed ID: 34020641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease.
    Walters JA; Tan DJ; White CJ; Wood-Baker R
    Cochrane Database Syst Rev; 2014 Dec; (12):CD006897. PubMed ID: 25491891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease.
    Schweiger TA; Zdanowicz M
    Am J Health Syst Pharm; 2010 Jul; 67(13):1061-9. PubMed ID: 20554591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of medical expenditure with nebulized budesonide versus systemic corticosteroids in hospitalized patients with acute exacerbations of chronic obstructive pulmonary disease in China.
    Zhang J; Yao W; You X; Liu T; Liu Y
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1195-1207. PubMed ID: 31213797
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic corticosteroid for COPD exacerbations, whether the higher dose is better? A meta-analysis of randomized controlled trials.
    Cheng T; Gong Y; Guo Y; Cheng Q; Zhou M; Shi G; Wan H
    Clin Respir J; 2013 Oct; 7(4):305-18. PubMed ID: 23072733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease.
    Walters JA; Wang W; Morley C; Soltani A; Wood-Baker R
    Cochrane Database Syst Rev; 2011 Oct; (10):CD006897. PubMed ID: 21975757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of Nebulized Budesonide in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
    Zhang R; Zhu J; Liu Y; Li Y; Liu W; Zhang M; Chen B; Zhu S
    Int J Chron Obstruct Pulmon Dis; 2020; 15():409-415. PubMed ID: 32161453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute exacerbations of chronic obstructive pulmonary disease: diagnosis, management, and prevention in critically ill patients.
    Dixit D; Bridgeman MB; Andrews LB; Narayanan N; Radbel J; Parikh A; Sunderram J
    Pharmacotherapy; 2015 Jun; 35(6):631-48. PubMed ID: 26032691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial.
    Devereux G; Cotton S; Barnes P; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; De Soyza A; Fielding S; Gompertz S; Haughney J; Lee AJ; McCormack K; McPherson G; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Trials; 2015 Jun; 16():267. PubMed ID: 26058585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe acute exacerbations of chronic obstructive pulmonary disease: does the dosage of corticosteroids and type of antibiotic matter?
    Kiser TH; Vandivier RW
    Curr Opin Pulm Med; 2015 Mar; 21(2):142-8. PubMed ID: 25575365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exacerbation Frequency And Eosinophil Counts Among Patients With COPD Currently Prescribed Triple Therapy.
    Benson VS; Pascoe KC; Siddall J; Small M; Müllerová H
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2711-2723. PubMed ID: 31819403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic corticosteroids in chronic obstructive pulmonary disease: an overview of Cochrane systematic reviews.
    Wood-Baker R; Walters J; Walters EH
    Respir Med; 2007 Mar; 101(3):371-7. PubMed ID: 16962307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing our understanding of the time course of acute exacerbations of COPD managed on an outpatient basis.
    Oliveira A; Afreixo V; Marques A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3759-3766. PubMed ID: 30538438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of glucocorticoids in patients with COPD exacerbations in China: a retrospective observational study.
    Zhang J; Zheng J; Huang K; Chen Y; Yang J; Yao W
    Ther Adv Respir Dis; 2018; 12():1753466618769514. PubMed ID: 29692212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care.
    Bathoorn E; Groenhof F; Hendrix R; van der Molen T; Sinha B; Kerstjens HA; Friedrich AW; Kocks JW
    Int J Chron Obstruct Pulmon Dis; 2017; 12():285-290. PubMed ID: 28144133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.